Biotech Values

[rfj1862]

LOL quite a bit of enthusiasm for VKTX. I've made good money in biotech over the years but it is nice to be in the middle of the hottest biotech...ever? Anyone want to poke holes in VKTX? I think I'm overconfident.

"The truly astonishing part to this story, though, is that Viking's stock might still be incredibly undervalued. Here's a quick overview on why this sizzling growth stock may increase tenfold before year's end."

"The truly astonishing part to this story, though, is that Viking's stock might still be incredibly undervalued. Here's a quick overview on why this sizzling growth stock may increase tenfold before year's end."

"Who might be a suitor? Pfizer, Bristol Myers Squibb, and Gilead Sciences have all attempted to develop NASH drugs in the past with little to show for it. What's more, all three of these biopharma heavyweights have the financial firepower to acquire Viking with ease."

"Bottom line: Viking has a realistic pathway toward a $12 billion-plus valuation by the close of 2023, depending on the outcomes of VK2809 in NASH, VK2735 in obesity, and interest from possible suitors."

https://www.fool.com/investing/2023/03/29/up-463-this-sizzling-growth-stock-could-have-a-lot/